GlassScriptPhysician profile
Rupinderjit K Samra
NPI 1912139114
$3,208.98
in general payments reported to CMS, 2019-2025
22 companies · $781 in 2025
The $781 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,203 · 2022: $437 · 2023: $118 · 2024: $670 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $521.35 | 2021-2025 | Tezspire |
| Tandem Diabetes Care, INC. | $330.71 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $312.06 | 2021-2024 | Spravato, Xarelto |
| Biohaven Pharmaceuticals, INC. | $287.51 | 2021 | |
| Novo Nordisk INC | $203.59 | 2021-2025 | |
| Abbvie INC. | $146.34 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $145.35 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.48 | 2021 | |
| Mayne Pharma Commercial LLC | $119.93 | 2024 | |
| Alk-Abello, INC | $118.98 | 2025 | |
| Lilly USA, LLC | $117.97 | 2021 | |
| Cvrx, INC. | $116.76 | 2022 | |
| Alkermes, INC. | $114.39 | 2025 | Vivitrol |
| Gilead Sciences, INC. | $112.61 | 2024 | Biktarvy |
| Teva Pharmaceuticals USA, INC. | $102.38 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $92.06 | 2022 | |
| Cordis US Corp. | $84.09 | 2025 | Infiniti, Mynx Control Venous, Mynx Control |
| Merck Sharp & Dohme LLC | $58.53 | 2021 | |
| Biodelivery Sciences International, INC. | $36.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.98 | 2021 | |
| Hologic Sales and Service, LLC | $16.91 | 2021 | |
| Glaxosmithkline, LLC. | $14.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupinderjit Samra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.